Digital Breast Tomosynthesis Reduces Rate of Interval Cancers (IMAGE)
Caption
Images in a 43-year-old woman diagnosed with a 13-mm lymph node-positive invasive ductal carcinoma luminal B-like human epidermal growth factor receptor 2 breast cancer 7 months after a screening negative for cancer in the Malmö Breast Tomosynthesis Screening Trial. (a) Mediolateral and (b) craniocaudal digital mammography (DM) images at screening. (c) Digital breast tomosynthesis screening image. (d) Mediolateral and (e) craniocaudal DM images at diagnosis with a small marker at lump location. The breast cancer is difficult to distinguish. (f) US image at diagnosis; breast cancer clearly visible.
Credit
Radiological Society of North America
Usage Restrictions
May use with credit.
License
Licensed content